Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hong Kong Pharma Digital Technology Holdings Ltd. ( (HKPD) ) has provided an announcement.
On November 6, 2025, Hong Kong Pharma Digital Technology Holdings Ltd. announced the resignation of two independent directors, Ms. Raina Zou and Dr. King Yin Lai, citing personal reasons. Their departures did not stem from any disagreements with the company’s operations or policies. To fill the vacancies, the company appointed Ms. Jingyan Wu and Mr. Yao Mike Zhou as independent directors, effective the same day. Ms. Wu, with over 20 years of experience in accounting and auditing, will serve as chairperson of the audit committee, while Mr. Zhou will chair the compensation committee. These appointments aim to maintain the company’s governance and operational stability.
More about Hong Kong Pharma Digital Technology Holdings Ltd.
Hong Kong Pharma Digital Technology Holdings Ltd. operates in the pharmaceutical and digital technology industry, focusing on innovative solutions and services that integrate digital advancements with pharmaceutical applications.
Average Trading Volume: 2,971,551
Technical Sentiment Signal: Strong Sell
Current Market Cap: $13.2M
For detailed information about HKPD stock, go to TipRanks’ Stock Analysis page.